Augur Signals: News Feed

In a notable move, Williams Gregg, a major insider at Vivani Medical, Inc. (VANI), has bolstered their holdings with a new acquisition of 7,620 shares at $1.01 each, totaling $7,696.20. This purchase increases Gregg's total ownership to 721,411 shares, showcasing a robust belief in the firm's future. Over the past year, Gregg has consistently invested in VANI, with share prices ranging from $0.86 to $1.08. Amidst the biotech sector's volatility, VANI maintains a steady share price with a market cap of USD 50,818,800, cash reserves of USD 32,486,000, and debt of USD 20,988,000 …

McWherter Charles, President of R&D at CymaBay Therapeutics, Inc. (CBAY), sold 2,250 shares at $23.67 each, totaling $55,125. Remaining with 15,000 shares, McWherter's transaction coincides with CymaBay's stock volatility and growth. With 192 insider transactions over the past year, McWherter's activity reflects a pattern of option exercises and sales. Despite operating at a loss, CymaBay's cash reserves of USD 213,844,000 bolster its clinical research endeavors. The sale may indicate personal financial planning rather than a judgment on CymaBay's future.

On January 9, 2024, Mendelson Daniel Newman, a director at Champions Oncology, Inc., bought 3,000 shares at $6.25 per share, totaling $18,720.00. This insider transaction signifies confidence in the firm, as Newman's stake reaches 192,681 shares. Amidst share price volatility, with significant changes over ten days and fifty-two weeks, Newman's consistent purchases over the past year reflect an optimistic outlook. Champions Oncology, Inc., a player in the Healthcare and Biotechnology sectors, shows a strong financial position, with a market cap of $86,806,048 and revenues of $52,686,000. Investors are encouraged to weigh this insider …